FABP9 as a potential therapeutic target for tumors: Inhibiting FABP9 can reduce tumor cell invasiveness, especially in FABP9-overexpressing liver cancer, and targeted intervention may become a new strategy[156]. The gene discussed is FABP9; the disease is liver cancer.